Nu Skin Enterprises, Inc. · Consumer Staples · Household & Personal Products
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$8.48
−$0.16 (−1.80%) 4:00 PM ET
Pre-market$8.48
+$0.01 (+0.06%) 8:28 PM ET
Prev closePrevC$8.63
OpenOpen$8.48
Day highHigh$8.60
Day lowLow$8.41
VolumeVol457,727
Avg volAvgVol575,816
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$408.12M
P/E ratio
2.67
FY Revenue
$1.49B
EPS
3.18
Gross Margin
69.45%
Sector
Consumer Staples
AI report sections
MIXED
NUS
Nu Skin Enterprises, Inc.
No AI report section text found yet for this symbol.
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
The global derma roller market is expected to grow from $303.14 million in 2023 to $668.17 million by 2033, driven by increasing demand for non-invasive cosmetic procedures and growing interest in skincare products.
The article does not mention any significant developments or performance for this company, so a neutral sentiment is assigned.
NegativeThe Motley Fool• Eric Volkman
Why Nu Skin Enterprises Stock Flopped on Friday
Nu Skin Enterprises (NUS) shares fell over 3% after the company reported a 12% year-over-year decline in Q2 revenue and a steep drop in non-GAAP net income, despite beating analyst estimates. The company provided guidance for Q3 and full-year 2024, but the earnings forecast fell short of expectations.
NUSNu Skin Enterprisesearningsrevenueguidance
Sentiment note
The company reported a decline in revenue and a steep drop in net income, leading to a 3% decline in the stock price, despite beating analyst estimates. The company's guidance for Q3 and 2024 also fell short of expectations.
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin (NUS) Troubled by Customer Acquisition Challenges
Nu Skin (NUS) has been battling persistent macroeconomic headwinds across most regions, which has affected customer and affiliate acquisition.
INGRNUSVITLUTZ
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NUSHELE
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.
HRLTSNNUSBYND
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
Nu Skin (NUS) delivered earnings and revenue surprises of 80% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
NUSEWCZ
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin (NUS) Q1 Earnings Coming Up: Factors to Consider
Nu Skin's (NUS) first-quarter 2024 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations are a concern.
DGIFFNUSOLLI
UnknownZacks Investment Research• Zacks Equity Research
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
Smart Beta ETF report for PEY
PEYKWNUSWBA
UnknownZacks Investment Research• Zacks Equity Research
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IPARNUS
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NUSEL
UnknownZacks Investment Research• Zacks Equity Research
Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why
Nu Skin (NUS) is battling macroeconomic challenges, with inflation putting pressure on consumer spending and customer acquisition. Management expects revenues to decline in 2024.
NUSPOSTLWVITL
UnknownBenzinga• Avi Kapoor
Top 4 Risk Off Stocks That May Explode In February
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.
Herbalife Ltd. (NYSE: HLF)
On Feb. 14, Herbalife reported mixed fourth-quarter financial results. The company’s stock fell around 32% over the past five days and has a 52-week low of $6.68 .
RSI Value: 28.29
HLF Price Action: ...
HLFNUSUVVSNAXLong IdeasNewsPenny StocksSmall Cap
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
